178 related articles for article (PubMed ID: 35599502)
1. Fluid and electrolyte management in preterm infants with patent ductus arteriosus.
Lalitha R; Surak A; Bitar E; Hyderi A; Kumaran K
J Neonatal Perinatal Med; 2022; 15(4):689-697. PubMed ID: 35599502
[TBL] [Abstract][Full Text] [Related]
2. The effect of hemodynamically significant patent ductus arteriosus on acute kidney injury and systemic hypertension in extremely low gestational age newborns.
Velazquez DM; Reidy KJ; Sharma M; Kim M; Vega M; Havranek T
J Matern Fetal Neonatal Med; 2019 Oct; 32(19):3209-3214. PubMed ID: 29642731
[No Abstract] [Full Text] [Related]
3. Clinical and echocardiographic characteristics associated with evolution of patent ductus arteriosus in preterm neonates: A prospective cohort study.
Saha AK; Sardar SK; Majhi B; Chatterjee S
J Neonatal Perinatal Med; 2022; 15(3):537-544. PubMed ID: 35599501
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting successful closure of hemodynamically significant patent ductus arteriosus with indomethacin in extremely low birth weight infants.
Yang CZ; Lee J
World J Pediatr; 2008 May; 4(2):91-6. PubMed ID: 18661761
[TBL] [Abstract][Full Text] [Related]
5. Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants.
ElHassan NO; Bird TM; King AJ; Ambadwar PB; Jaquiss RD; Kaiser JR; Robbins JM
J Neonatal Perinatal Med; 2014 Jan; 7(3):229-35. PubMed ID: 25322995
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants.
Mosalli R; Alfaleh K
Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD006181. PubMed ID: 18254095
[TBL] [Abstract][Full Text] [Related]
7. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
Herrera C; Holberton J; Davis P
Cochrane Database Syst Rev; 2007 Apr; 2007(2):CD003480. PubMed ID: 17443527
[TBL] [Abstract][Full Text] [Related]
8. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Shah SS
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004213. PubMed ID: 31985838
[TBL] [Abstract][Full Text] [Related]
9. Reply to the comment on "Fluid restriction in management of patent ductus arteriosus in Italy: a nationwide survey".
Francescato G; Capolupo I; Cerbo RM; Doni D; Ficial B; Fiocchi S; Matina F; Milani GP; Mizzoni F; Salvadori S; Savoia M; Corsini I
Eur J Pediatr; 2023 Apr; 182(4):1931-1932. PubMed ID: 36658445
[TBL] [Abstract][Full Text] [Related]
10. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Shah SS
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004213. PubMed ID: 31222841
[TBL] [Abstract][Full Text] [Related]
11. Fluid restriction in management of patent ductus arteriosus in Italy: a nationwide survey.
Francescato G; Capolupo I; Cerbo RM; Doni D; Ficial B; Fiocchi S; Matina F; Milani GP; Mizzoni F; Salvadori S; Savoia M; Corsini I
Eur J Pediatr; 2023 Jan; 182(1):393-401. PubMed ID: 36374300
[TBL] [Abstract][Full Text] [Related]
12. Overview of transcatheter patent ductus arteriosus closure in preterm infants.
Almeida-Jones M; Tang NY; Reddy A; Zahn E
Congenit Heart Dis; 2019 Jan; 14(1):60-64. PubMed ID: 30811790
[TBL] [Abstract][Full Text] [Related]
13. Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants.
Mitra S; Scrivens A; von Kursell AM; Disher T
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013278. PubMed ID: 33301630
[TBL] [Abstract][Full Text] [Related]
14. Paracetamol Treatment for Patent Ductus Arteriosus, an Apparent Association with Acute Hemolysis in Three Preterm Infants: Case Series.
Bauer-Rusek S; Samra N; Moore SS; Arnon S
Neonatology; 2022; 119(4):530-534. PubMed ID: 35728580
[TBL] [Abstract][Full Text] [Related]
15. Effects of maternal aspirin treatment on hemodynamically significant patent ductus arteriosus in preterm infants - pilot study.
Fridman E; Mangel L; Mandel D; Beer G; Kapusta L; Marom R
J Matern Fetal Neonatal Med; 2022 Mar; 35(5):958-963. PubMed ID: 32138560
[TBL] [Abstract][Full Text] [Related]
16. Identifying two distinct subphenotypes of patent ductus arteriosus in preterm infants using machine learning.
Matsushita FY; Krebs VLJ; de Carvalho WB
Eur J Pediatr; 2023 May; 182(5):2173-2179. PubMed ID: 36853570
[TBL] [Abstract][Full Text] [Related]
17. Practice variation in the management of patent ductus arteriosus in extremely low birth weight infants in the United States: Survey results among cardiologists and neonatologists.
Sathanandam S; Whiting S; Cunningham J; Zurakowski D; Apalodimas L; Waller BR; Philip R; Qureshi AM
Congenit Heart Dis; 2019 Jan; 14(1):6-14. PubMed ID: 30811803
[TBL] [Abstract][Full Text] [Related]
18. Clinical and echocardiography predictors of response to first-line acetaminophen treatment in preterm infants with hemodynamically significant patent ductus arteriosus.
Moronta SC; Bischoff AR; Ryckman KK; Dagle JM; Giesinger RE; McNamara PJ
J Perinatol; 2024 Mar; 44(3):379-387. PubMed ID: 38297179
[TBL] [Abstract][Full Text] [Related]
19. Oral ibuprofen is superior to oral paracetamol for patent ductus arteriosus in very low and extremely low birth weight infants.
Lu J; Li Q; Zhu L; Chen C; Li Z
Medicine (Baltimore); 2019 Aug; 98(31):e16689. PubMed ID: 31374055
[TBL] [Abstract][Full Text] [Related]
20. ACETAMINOPHEN ADMINISTERING IN ORDER TO OBLITERATE HEMODYNAMICALLY SIGNIFICANT PATENT DUCTUS ARTERIOSUS IN NEONATES WITH EXTREMELY LOW BIRTH WEIGHT.
Aleksandrovich YS; Khubulava GG; Chupaeva OY; Naumov AB; Marchenko SP; Melashenko TB; Pshenisnov KV; Li AG
Anesteziol Reanimatol; 2016 Nov; 61(6):438-442. PubMed ID: 29894612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
